What is Hemoglobin H (HbH) inclusion associated with?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hemoglobin H Inclusions: Associated Conditions

Hemoglobin H (HbH) inclusions are primarily associated with alpha-thalassemia, specifically HbH disease, which results from severe reduction in alpha-globin chain production affecting three of the four alpha-globin genes. 1, 2

Primary Association: Alpha-Thalassemia and HbH Disease

HbH disease is the most common form of thalassemia intermedia and represents the condition most strongly associated with HbH inclusions. 2 The disease occurs when alpha-globin chain production is reduced to approximately the output of a single alpha-globin gene, leading to formation of HbH (β₄ tetramers) due to the relative excess of beta chains. 1

Genetic Mechanisms

  • Deletional forms: Most commonly result from double heterozygosity for alpha⁰-thalassemia (deletion of both linked alpha-globin genes) combined with alpha⁺-thalassemia (single alpha-globin gene deletion), producing the --/-α genotype. 2

  • Non-deletional forms: Occur from interactions between alpha⁰-thalassemia with non-deletional mutations (α^T^α or α^T^) or with abnormal hemoglobins such as Hb Constant Spring, Hb Paksé, Hb Quong Sze, and Hb Pak Num Po. 2 These non-deletional mutations typically cause more severe clinical expression with greater anemia, significant splenomegaly, and higher transfusion requirements. 2, 3

Detection in Alpha-Thalassemia Carriers

HbH inclusions can be detected in heterozygous alpha-thalassemia carriers (alpha-thalassemia trait), though they are rare. 4 The majority of carriers investigated—including those with deletion of a single or two alpha-globin genes and those with non-deletion lesions—have rare red blood cells with HbH inclusions, with no significant difference in frequency related to the specific alpha-globin genotype. 4

Diagnostic Utility

  • Diagnosis of HbH disease involves hemoglobin electrophoresis showing the presence of HbH and peripheral blood smear examination revealing HbH inclusion bodies. 1

  • Parents of affected individuals can be screened by evaluating mean cell volume (MCV), which will be <80 fL in thalassemia carriers. 1

Rare Association: Alpha-Thalassemic Hemoglobinopathies

HbH inclusions may rarely appear in specific alpha-globin chain variants, such as homozygosity for Hb Agrinio [α29(B10)Leu→Pro]. 5 In one reported case, a patient homozygous for this highly unstable variant initially presented with very rare Hb H inclusions at 12 months of age, though these were not detected at 13 years despite persistent mild thalassemia intermedia phenotype. 5

Clinical Context and Severity

  • In steady state, patients with HbH disease typically maintain hemoglobin levels around 9-10 g/dL. 2

  • During hemolytic crises—frequently triggered by acute infections with high fever—hemoglobin levels may drop significantly, potentially leading to shock or renal shutdown. 2

  • Non-deletional HbH disease demonstrates greater ineffective erythropoiesis, hemolysis, higher transfusion burden, and increased complication risks compared to deletional mutations. 3

  • High HbH levels exacerbate anemia by negatively influencing tissue oxygenation, and both HbH and alpha-thalassemic hemoglobin variants reduce red cell survival within bone marrow and circulation. 6

Key Diagnostic Pitfall

Do not confuse HbH disease with beta-thalassemia trait—both present with microcytic anemia (MCV <80 fL), but HbH disease is part of the non-transfusion-dependent thalassemia spectrum and may require transfusions to prevent cardiovascular and other complications as patients age. 7

References

Guideline

Hemoglobin Variants in Hematological Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hb H disease: clinical course and disease modifiers.

Hematology. American Society of Hematology. Education Program, 2009

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.